FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

SterRx fentaNYL Citrate in 0 Recall

fentaNYL Citrate in 0

SterRx, LLC · Plattsburgh, NY

Risk level
Class II
Reported by FDA
Aug 17, 2022
Recall ID
D-1332-2022
Check your lot numberHow we source this data

Summary

SterRx recalled fentaNYL Citrate in 0 starting Jul 25, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1332-2022 on Aug 17, 2022. Reason: Lack of Assurance of Sterility. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility

Product description

fentaNYL Citrate in 0.9% Sodium Chloride, 2.5 mg per 250 mL, (10 mcg per mL) IV bags, Rx Only, SterRx, 141 Idaho Avenue, Plattsburgh, NY 12903, NDC 70324-327-02.

Lot numbers, UPCs & expiration codes

Lot #: CHL, Exp. Date Dec 29, 2022

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1332-2022
Classification
Class II
Status
Terminated
Recall initiated
Jul 25, 2022
FDA report date
Aug 17, 2022
Quantity
360 bags
Recall type
Voluntary: Firm initiated
Recalling firm
SterRx, LLC

Original FDA data

Every field from FDA enforcement report D-1332-2022, exactly as published.

Show all FDA fields
City
Plattsburgh
State
NY
Status
Terminated
Country
United States
Event ID
90653
Address
141 Idaho Ave
Code information
Lot #: CHL, Exp. Date Dec 29, 2022
Postal code
12903-3987
Report date
Aug 17, 2022
Product type
Drugs
Recall number
D-1332-2022
Classification
Class II
Recalling firm
SterRx, LLC
Product quantity
360 bags
Termination date
Jun 22, 2023
Reason for recall
Lack of Assurance of Sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
fentaNYL Citrate in 0.9% Sodium Chloride, 2.5 mg per 250 mL, (10 mcg per mL) IV bags, Rx Only, SterRx, 141 Idaho Avenue, Plattsburgh, NY 12903, NDC 70324-327-02.
Distribution pattern
Nationwide within the United States
Recall initiation date
Jul 25, 2022
Initial firm notification
Letter
Center classification date
Aug 9, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1332-2022, published Aug 17, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls